Compléments alimentaires, confrontés aux preuves

Berberine

Solidité des preuves: Partiellement étayé

Mis à jour 2026-08-07

Ce guide n’est pas encore traduit dans votre langue ; il est affiché en anglais.

Réponse courte

Does berberine lower blood sugar?

Pooled trial data show berberine reducing HbA1c by about 0.63 percentage points and fasting glucose by about 0.8 mmol/L in type 2 diabetes — a real effect, larger than any other supplement reviewed here. The literature is dominated by trials from a single region with known quality concerns, and berberine has genuine drug interactions. It is not a supplement to start without telling your prescriber.

Avant d’en prendre

Parlez-en à votre prescripteur avant d’ajouter ceci à un médicament, en particulier hypoglycémiant. N’arrêtez jamais un traitement prescrit au profit d’un complément.

Interactions

  • Additive with glucose-lowering medication. Taken alongside metformin, insulin or a sulfonylurea, berberine can push glucose lower than either was meant to — a hypoglycaemia risk that rises with the drugs most likely to be in our readers' cabinets.1

    À éviter

  • Inhibits intestinal P-glycoprotein, raising blood levels of drugs that depend on it. In animals, berberine increased digoxin exposure by up to 70% and ciclosporin exposure by up to 96%. Both have narrow margins between a working dose and a toxic one.2

    À éviter

  • Modelling that accounts for both CYP3A and P-glycoprotein inhibition predicts high-dose berberine (300 mg three times daily) will raise exposure to some CYP3A substrates. These are simulations, not measured human interactions, and the authors call for controlled studies.3

    Prudence

Qui ne doit pas en prendre

  • Not for use in pregnancy or while breastfeeding. Berberine crosses the placenta and is excreted in breast milk, and it displaces bilirubin from albumin — the mechanism behind kernicterus in newborns.

    À éviter

  • Not for infants or young children, for the same reason.

    À éviter

  • If you take any prescription medicine at all, talk to your prescriber before starting berberine rather than after. This is the supplement on this site with the most real interaction potential.

    Prudence

Notre verdict

The strongest evidence of anything on this page, from the weakest evidence base — and with real interaction risk attached. Worth discussing with a prescriber; not worth starting quietly.

Ce que nous pouvons dire et vendre chez vous

Les allégations de santé pour ces produits ne sont pas autorisées dans votre région. Cette page ne comporte donc aucun lien commercial : elle est purement informative.

Aucun lien commercial n’est affiché dans votre région.

Comment lire les étiquettes de preuve

Chaque affirmation de cette page porte une étiquette indiquant le poids qu’elle peut supporter. Elle décrit la solidité du résultat, non le prestige de la revue.

  • Preuves solidesUn grand essai randomisé, une cohorte suivie longtemps, ou la concordance de plusieurs d’entre eux.
  • Preuves émergentesRéel, mais mince — petit, court, observationnel ou non encore répliqué.
  • ContestéDes chercheurs compétents sont en désaccord. Nous ne tranchons pas à votre place.

What the trials found

A 2022 meta-analysis pooled 37 randomised trials covering 3,048 people with type 2 diabetes. The effect sizes are not trivial: reductions on the order of a modest pharmaceutical.

The same analysis reported no increase in total adverse events or in hypoglycaemia risk when berberine was used alone or alongside oral glucose-lowering drugs — though that is a different question from whether it is safe alongside every other medication someone might be taking.

Ce que disent les preuves

  • Across 37 randomised trials in 3,048 people with type 2 diabetes, berberine reduced HbA1c by 0.63 percentage points, fasting glucose by 0.82 mmol/L and two-hour post-load glucose by 1.16 mmol/L.1

    Preuves émergentes

  • The size of the effect depended on how high the participant's baseline glucose and HbA1c were — the benefit concentrates in people whose numbers were worst to begin with.1

    Preuves émergentes

Why we tier this as emerging, not strong

The pooled figures look impressive, and the evidence base underneath them is not. That analysis searched four Chinese-language databases alongside the international ones, and the berberine trial literature is heavily concentrated in trials published there — a body of work with documented concerns about methodological quality and publication bias.

This is not a claim that the trials are wrong. It is a statement about how much a pooled average from that literature can be relied on, and the honest answer is: less than the confidence interval suggests. Larger, independently run trials would settle it.

Ce que disent les preuves

  • The pooled berberine evidence draws substantially on trials indexed in Chinese-language databases, a literature with recognised quality and publication-bias concerns.1

    Preuves émergentes

The interaction problem

Berberine inhibits intestinal P-glycoprotein, the transporter that limits how much of certain drugs get absorbed. Block it and those drugs reach higher levels than prescribed. In animal work, digoxin and ciclosporin exposure both rose substantially — two drugs where the gap between therapeutic and toxic is narrow.

Our audience is the reason this matters more here than on a general wellness site. People reading about glucose supplements are disproportionately people already taking glucose-lowering drugs, and berberine's effect is additive with all of them.

Ce que disent les preuves

  • Berberine increased digoxin exposure by up to 70% and ciclosporin exposure by up to 96% in animal studies, through inhibition of intestinal P-glycoprotein.2

    Preuves émergentes

  • The same animal work found no significant change in CYP3A activity, while pharmacokinetic modelling predicts clinically relevant CYP3A-mediated interactions at high berberine doses — the two lines of evidence do not fully agree.2,3

    Preuves émergentes

Questions fréquentes

Is berberine as good as metformin?
Some trials compare the two directly and report similar glucose reductions, but they are small and mostly from one literature. Metformin has decades of outcome data behind it and berberine does not. They are not interchangeable, and swapping one for the other is a decision for a prescriber.
Can I take berberine with metformin?
Their effects on glucose add up, which can push you lower than either dose intended. That is a conversation to have with whoever prescribed the metformin before you start, not after.
How long does the effect last?
Most trials in the pooled analysis ran for a few months. There is little long-term data, and no trial has shown that berberine reduces the complications that matter — only the numbers that predict them.

Références

  1. 1.Xie W, Su F, Wang G, Peng Z, Xu Y, Zhang Y, et al. (2022). Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Frontiers in Pharmacology. 10.3389/fphar.2022.1015045
  2. 2.Qiu W, Jiang XH, Liu CX, Ju Y, Jin JX (2009). Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp. Phytotherapy Research. 10.1002/ptr.2808
  3. 3.Adiwidjaja J, Boddy AV, McLachlan AJ (2022). Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib. European Journal of Clinical Pharmacology. 10.1007/s00228-021-03266-y

À lire ensuite